Successful Retreatment of a Child with a Refractory Brainstem Ganglioglioma with Vemurafenib-Reference-Cited by-同舟云学术

Successful Retreatment of a Child with a Refractory Brainstem Ganglioglioma with Vemurafenib

Published:2015-11-18 Issue:3 Volume:63 Page:541-543
ISSN:1545-5009
Container-title:Pediatric Blood & Cancer
language:en
Short-container-title:Pediatr Blood Cancer

Author:

Aguilera Dolly¹,Janss Anna¹,Mazewski Claire¹,Castellino Robert Craig¹,Schniederjan Matthew²,Hayes Laura³,Brahma Barunashish⁴,Fogelgren Lauren⁵,MacDonald Tobey J.¹

Affiliation:

1. Aflac Cancer & Blood Disorders Center; Children's Healthcare of Atlanta; Emory University School of Medicine; Atlanta Georgia

2. Department of Pathology; Emory University School of Medicine; Atlanta Georgia

3. Department of Radiology; Children's HealthCare of Atlanta at Scottish Rite; Atlanta Georgia

4. Department of Neurosurgery; Children's Health Care of Atlanta; Emory University; School of Medicine; Atlanta Georgia

5. Aflac Cancer & Blood Disorders Center; Children's Healthcare of Atlanta; Atlanta Georgia

Publisher

Wiley

Subject

Oncology,Hematology,Pediatrics, Perinatology and Child Health

Reference13 articles.

1. Pediatric low-grade ganglioglioma: Epidemiology, treatments, and outcome analysis on 348 children from the surveillance, epidemiology, and end results database;Dudley;Neurosurgery,2015

2. Central nervous system gangliogliomas. Part 2: Clinical outcome;Lang;J Neurosurg,1993

3. Pediatric brainstem gangliogliomas show BRAF(V600E) mutation in a high percentage of cases;Donson;Brain Pathol,2014

4. Radiation therapy and malignant degeneration of benign supratentorial gangliogliomas;Rumana;Neurosurgery,1998

5. Pediatric infratentorial gangliogliomas: A retrospective series;Baussard;J Neurosurg,2007

Cited by 47 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Phase II study of vemurafenib in children and young adults with tumors harboring BRAF V600 mutations: NCI-COG pediatric MATCH trial (APEC1621) Arm G;The Oncologist;2024-06-14

2. Chemotherapy in pediatric low-grade gliomas (PLGG);Child's Nervous System;2024-05-31

3. Unlocking the power of precision medicine for pediatric low-grade gliomas: molecular characterization for targeted therapies with enhanced safety and efficacy;Frontiers in Oncology;2023-06-15

4. Brain and Spinal Cord Tumors Among the Life-Threatening Health Problems: An Introduction;Advances in Experimental Medicine and Biology;2023

5. Early molecular diagnosis of BRAF status drives the neurosurgical management in BRAF V600E-mutant pediatric low-grade gliomas: a case report;BMC Pediatrics;2022-11-29